If you're looking for a straightforward answer: provider-guided compounded tirzepatide programs typically range from $199–$299+ per month depending on the provider, supply length, and what's included in the program.
Here's the full breakdown:
Belle offers three supply options for compounded tirzepatide:
The 6-month supply offers the lowest monthly cost and is the option most patients choose once they've confirmed tirzepatide is the right fit.
All Belle programs include licensed provider consultation, ongoing clinical oversight, titration support, registered dietitian guidance through the Thriving on GLP-1s video series, weekly live patient webinars, and patient portal access. The medication and the care program are included in a single monthly price.
Other compounded tirzepatide programs range from roughly $129–$399/month depending on the provider. Lower-cost programs often offer less clinical oversight — no ongoing provider access, no nutrition support, and minimal titration guidance. Higher costs don't always mean better care; the program structure matters more than the price.
Brand-name GLP-1 options typically run $350–$1,000+ per month without insurance coverage. Insurance coverage for weight management indications varies significantly and is not guaranteed.
A few things drive variation in pricing across compounded tirzepatide programs:
Supply length. Most programs charge less per month for longer supply commitments. A 6-month supply typically costs meaningfully less per month than buying one month at a time.
What's included. Some programs charge separately for provider consultations, titration adjustments, or nutrition support. Others — like Belle — bundle everything into a single monthly price. The comparison that matters is total cost of care, not just the medication cost.
Pharmacy quality. Programs partnering with 503B outsourcing facilities or PCAB-accredited pharmacies may charge more than those using lower-tier compounders. Quality standards in sterile compounding have real implications for what you're actually receiving.
That depends on what you're comparing it to.
Compared to brand-name options at $350–$1,000+/month out of pocket, a well-structured compounded tirzepatide program is substantially more accessible — often by hundreds of dollars per month.
Compared to doing nothing while continuing to struggle with appetite dysregulation, metabolic health challenges, and the downstream costs those can create, most patients find the investment straightforward to justify.
The more useful question isn't whether it's worth it in the abstract — it's whether the specific program you're considering includes the clinical support that makes the medication actually work long-term.
Belle's provider-guided compounded tirzepatide program starts at $199/month on a 6-month supply. The intake process begins with a licensed provider consultation to determine whether tirzepatide is appropriate for you.
Start at apply.joinbelle.com. Current patients can reach their care team through portal.joinbelle.com.
If tirzepatide is outside your budget, Belle also offers provider-guided compounded semaglutide starting at $119/month (6-month supply). Semaglutide is a GLP-1 receptor agonist with a strong track record in weight management and the same level of clinical oversight Belle provides for all programs.
Learn more about Belle's compounded semaglutide program at apply.joinbelle.com.
Compounded tirzepatide is not an FDA-approved finished drug product. Pricing current as of March 2026 and subject to change. All prescribing decisions are made by licensed healthcare providers based on individual patient evaluation.
